Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transforming growth factor beta receptor type I (TGF-βRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDS.
Ramachandra N, Vegivinti CTR, Sahu S, Sanawar R, Rivera-Peña B, Aminov S, Fromowitz A, Zhang J, Aodengtuya F, Pradhan K, Zhao R, Schwartz L, Alluri S, Thiruvananthapuram V, Rabinovich E, Ajibade O, Gordon-Mitchell S, Shastri A, Deken M, Yingling JM, Sawyer S, Lahn M, Verma A. Ramachandra N, et al. Among authors: vegivinti ctr. Leuk Lymphoma. 2024 Dec 27:1-10. doi: 10.1080/10428194.2024.2444479. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39727008
Smoking carcinogen induced inflammation promotes lung carcinogenesis via IRAK4 activation.
Aggarwal RK, Sidoli S, Wang J, Sahu S, Sanawar R, Gupta V, Aluri S, Sukrithan V, Vegivinti CTR, Zavras PD, Verma D, Gordon-Mitchell S, Agarwal B, Verma T, Starczynowski DT, Steidl UG, Shastri A, Halmos B, LaFave LM, Cheng H, Verma A, Zou Y. Aggarwal RK, et al. Among authors: vegivinti ctr. Clin Cancer Res. 2024 Dec 20. doi: 10.1158/1078-0432.CCR-24-2182. Online ahead of print. Clin Cancer Res. 2024. PMID: 39704655
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review.
Vegivinti CTR, Keesari PR, Veeraballi S, Martins Maia CMP, Mehta AK, Lavu RR, Thakur RK, Tella SH, Patel R, Kakumani VK, Pulakurthi YS, Aluri S, Aggarwal RK, Ramachandra N, Zhao R, Sahu S, Shastri A, Verma A. Vegivinti CTR, et al. Exp Hematol Oncol. 2023 Jul 8;12(1):60. doi: 10.1186/s40164-023-00422-1. Exp Hematol Oncol. 2023. PMID: 37422676 Free PMC article. Review.
16 results